🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
At present, it is recommended to continue immunotherapy until progression o...
Status
Unknown
Location
ICO - Site Paul Papin
Start Date
2022-01-12
Trial ID
NCT05111197
Treatments Being Tested
Immune checkpoint blockade (ICB) therapy has become a milestone breakthroug...
Status
Not Yet Recruiting
Location
Daping Hospital, Army Medical University
Start Date
2026-04-01
Trial ID
NCT07459192
The purpose of this study is to evaluate the safety and efficacy of pembrol...
Status
Completed
Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Start Date
2021-10-07
Trial ID
NCT05008224
This study will measure PD-L1 expression in metastatic NSCLC (primary tumou...
Status
Unknown
Location
Guy's and St Thomas' NHS Foundation Trust
Start Date
2022-05-03
Trial ID
NCT04992715
Treatments Being Tested
This is a prospective, single center, single-arm clinical trial in 20 patie...
Status
Terminated
Location
Johns Hopkins University
Start Date
2021-02-01
Trial ID
NCT04524195
Treatments Being Tested
Search correlation between texture features in CT-PET 18 FDG and overexpres...
Status
Completed
Location
Uh Montpellier
Start Date
2018-04-01
Trial ID
NCT04309422
This is an observational cohort study designed to (1) evaluate whether Gall...
Status
Recruiting
Location
The First Affiliated Hospital of Xiamen University
Start Date
2025-08-30
Trial ID
NCT07137052
Various approaches are currently being developed for prostate cancer immuno...
Status
Active Not Recruiting
Location
CHU de Québec-Université Laval
Start Date
2020-01-10
Trial ID
NCT04009967
Treatments Being Tested
Background: Some people with prostate cancer have a rise in prostate-speci...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2018-03-20
Trial ID
NCT03315871
This phase II trial tests the addition of chemotherapy, with carboplatin an...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2026-04-24
Trial ID
NCT07195734